“…In the past the demonstration that ALA and PBG are pharmacologically inert (Goldberg, Paton and Thompson, 1954) has led to suggestions that there is a deficiency of a substance required to protect nerve function, or of pyridoxine (Ridley, 1969), or that the abnormality of porphyrin precursor metabolism is merely a spectacular side effect of a more fundamental metabolic disturbance (Neuberger, 1968) possibly involving oxidation of NADH (Tschudy and Bonkowski, 1972). Recently Becker, Viljoen, and Kramer (1971) The porphyrias: a review that ALA inhibits brain tissue ATPase and have suggested that in the acute phase of porphyria ALA is taken up by nerve tissue and causes paralysis of conduction by inhibition of the Na+-K+-dependent ATPase, while Feldman, Levere, Lieberman, Cardinal, and Watson (1971) have reported that PBG in concentrations similar to those found in the cerebrospinal fluid during acute attacks, and one of its non-enzymically produced condensation products porphobilin, produce presynaptic neuromuscular inhibition.…”